Genetics and pathophysiology of systemic sclerosis;Génétique et physiopathologie de la sclérodermie systémique

Bulletin de l'Academie Nationale de Medecine

Volumn 195, Issue 1, 2011, Pages 55-67

  Allanore, Yannick ^a   Boileau, Catherine ^b  

^a Institut Cochin   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Autoimmunity; Genetic; Genetics; Polymorphism; Scleroderma systemic

Indexed keywords

EID: 80052858420     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32136-3     Document Type: Article

References (35)

1. VARGA J., ABRAHAM D. - Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest., 2001,117, 557-67.
2. ALLANORE Y., DIEUDE P., BOILEAU C. - Genetic background of systemic sclerosis: autoimmune genes take centre stage. Rheumatology (Oxford), 2010, 49, 203-210.
3. TROJANOWSKA M. - Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat. Rev. Rheumatol., 2010,6,453-460.
4. LUNARDI C, DOLCINO M., PETERLANA D. ET al. - Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Med. 2006,3, e2.
5. DISTLER J.H., JUNGEL A., PILECKYTE M. ET al. - Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum., 2007,56,4203-4215. (Pubitemid 350262349)
6. DISTLER J.H., ALLANORE Y., AVOUAC J. ET al. - EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann. Rheum. Dis., 2009, 68, 163-168.
7. CHIZZOLINI C. - T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis. Curr. Opin. Rheumatol., 2008,20, 707-712.
8. TAN F.K., ZHOU X., MAYES M.D. et al. - Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford). 2006,45, 694-702. (Pubitemid 43985337)
9. RADSTAKE T.R., VAN BON L., BROEN J. et al. - The pronounced Thl7 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One. 2009,4, e5903.
10. HAMAGUCHI Y. - Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J. Dermatol, 2010,37,42-53.
11. DAOUSSIS D., LIOSSIS S.N., TSAMANDAS A.C. et al. - Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature. Semin. Arthritis Rheum., 2010,40, 127-136.
12. WANG Y., FAN P.S., KAHALEH B. - Association between enhanced type I collagen expression and epigenetic repression of the FLU gene in scleroderma fibroblasts. Arthritis Rheum, 2006, 54,2271-2279. (Pubitemid 44051084)
13. VARGA J., PASCHE B. - Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat. Rev. Rheumatol., 2009,5, 200-206.
14. ARNETT F.C, CHO M., CHATTERJEE S. et al. - Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum., 2001, 44, 1359-1362. (Pubitemid 32537534)
15. DIEUDE P. - Rheumatic diseases: environment and genetics. Joint Bone Spine. 2009, 76, 602-607.
16. FEGHALI-BOSTWICK C, MEDSGER T.A. JR, WRIGHT T.M. - Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum., 2003,48, 1956-1963. (Pubitemid 36828691)
17. WIPFF J., DIEUDE P., GUEDJ M. et al. - Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. Arthritis Rheum., 2010, 62, 3093-3100.
18. MANETTI M., ALLANORE Y., REVILLOD L. et al. - A genetic variation located in the promoter of the uPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. Arthritis Rheum., 2010 Oct 21. [Epub ahead of print].
19. ARNETT F.C, GOURH P., SHETE S. et al. - Major histocompatibility complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann. Rheum. Dis., 2010,69, 822-827.
20. RADSTAKE T.R., GORLOVA O., RUEDA B. et al. - Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat. Genet., 2010,42,426-429.
21. GOURH P., ARNETT F.C, TAN F.K. et al. - Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann. Rheum. Dis., 2010,69, 550-555.
22. ASSASSI S., MAYES M.D., ARNETT F.C. et al. - Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum. 2010,62, 589-598.
23. DIEUDE P., GUEDJ M., WIPPF J. et al. - Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum., 2009,60,225-233.
24. ITO I., KAWAGUCHI Y., KAWASAKI A. et al. - Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis Rheum., 2009, 60, 1845-1850.
25. DIEUDE P., GUEDJ M., WIPFF J. et al. - STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum. 2009,60, 2472-2479.
26. RUEDA B., BROEN J., SIMEON C. et al. - The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum. Mol. Genet., 2009,18, 2071-2077.
27. AVOUAC J., FORNROHR B.G., TOMCIK M. et al. - Inactivation of the transcription factor STAT4 prevents inflammation-driven fibrosis in systemic sclerosis animal models. Arthritis Rheum., 2010 Nov. 30. [Epub ahead of print].
28. DIAZ-GALLO L., GOURH P., BROEN J. et al. - Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann. Rheum. Dis., 2010 Dec. 3. [Epub ahead of print].
29. DIEUDE P., WIPFF J., GUEDJ M. et al. - BANKl is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum., 2009, 60, 3447-3454.
30. RUEDA B., GOURH P., BROEN J. et al. - BANKl functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians. Ann. Rheum. Dis., 2010,69,700-705.
31. GOURH P., AGARWAL S.K., MARTIN E. et al. - Association of the C8orfl3-BLK region with systemic sclerosis in North-American and European populations. J. Autoimmun., 2010, 34, 155-162.
32. ITO I., KAWAGUCHI Y., KAWASAKI A. et al. - Association of the FAM167A-BLK region with systemic sclerosis. Arthritis Rheum., 2010,62, 890-895.
33. BROEN J., GOURH P., RUEDA B. et al. - T-he FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes. Arthritis Rheum., 2009,60, 3815-3820.
34. LIAKOULI V., MANETTI M., PACINI A. et al. - The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. Ann. Rheum. Dis., 2009,68, 584-590.
35. DIEUDE P., GUEDJ M., WIPFF J. et al. - Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann. Rheum. Dis, 2010, 69, 1958- 1964.